Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

NCT05914818 · MarsiBionics · Updated 3 Nov 2023

What is being tested
EXPLORER V2
For
Cerebral Palsy; Acquired Brain Injury; Neuromuscular Diseases in Children
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 2 years to 14 years. About 30 people. The full rules are on the registry page.
Where
Spain (5 sites)
When
Starts or started 23 June 2023, ends 29 Sept 2023. Registered 22 June 2023.
Results
None posted yet.

In the researchers' words

The goal of this clinical trial is to analyze the usability and safety of the prototype gait exoskeleton EXPLORE V2 in children with neurological and neuromuscular disease. Participants will use the exoskeletons in their home and the community and variables regarding safety and usability will be measured and recorded.
ClinicalTrials.gov, NCT05914818

Sites

  • Hospital Universitario Gregorio MarañónMadrid, Spain
  • Hospital Infantil Universitario Niño Jesús-Servicio de RehabilitaciónMadrid, Spain
  • Hospital Universitario Niño Jesús-Servicio de Neuro OrtopediaMadrid, Spain
  • Hospital Universitario 12 de OctubreMadrid, Spain
  • Hospital Universitario La PazMadrid, Spain